Literature DB >> 27856043

Determination of disk diffusion susceptibility testing interpretive criteria using model-based analysis: development and implementation.

Glen DePalma1, John Turnidge2, Bruce A Craig3.   

Abstract

The determination of diffusion test breakpoints has become a challenging issue due to the increasing resistance of microorganisms to antibiotics. Currently, the most commonly-used method for determining these breakpoints is the modified error-rate bounded method. Its use has remained widespread despite the introduction of several model-based methods that have been shown superior in terms of precision and accuracy. However, the computational complexities associated with these new approaches has been a significant barrier for clinicians. To remedy this, we developed and examine the utility of a free online software package designed for the determination of diffusion test breakpoints: dBETS (diffusion Breakpoint Estimation Testing Software). This software package allows clinicians to easily analyze data from susceptibility experiments through visualization, error-rate bounded, and model-based approaches. We analyze four publicly available data sets from the Clinical and Laboratory Standards Institute using dBETS.
Copyright © 2016 Elsevier Inc. All rights reserved.

Keywords:  Antibiotics; Breakpoint Estimation; Disk Diffusion; Error-Rate Bounded; Minimum Inhibitory Concentration; Software Package; Susceptibility

Mesh:

Year:  2016        PMID: 27856043     DOI: 10.1016/j.diagmicrobio.2016.03.004

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  6 in total

1.  Performance of ceftazidime/avibactam susceptibility testing methods against clinically relevant Gram-negative organisms.

Authors:  E Wenzler; M Lee; T J Wu; K A Meyer; R K Shields; M H Nguyen; C J Clancy; R M Humphries; A T Harrington
Journal:  J Antimicrob Chemother       Date:  2019-03-01       Impact factor: 5.790

Review 2.  CLSI Methods Development and Standardization Working Group Best Practices for Evaluation of Antimicrobial Susceptibility Tests.

Authors:  Romney M Humphries; Jane Ambler; Stephanie L Mitchell; Mariana Castanheira; Tanis Dingle; Janet A Hindler; Laura Koeth; Katherine Sei
Journal:  J Clin Microbiol       Date:  2018-03-26       Impact factor: 5.948

3.  Evaluation of the Performance of Manual Antimicrobial Susceptibility Testing Methods and Disk Breakpoints for Stenotrophomonas maltophilia.

Authors:  Ayesha Khan; Cedric Pettaway; Jennifer Dien Bard; Cesar A Arias; Micah M Bhatti; Romney M Humphries
Journal:  Antimicrob Agents Chemother       Date:  2021-02-08       Impact factor: 5.191

4.  Correlation between Broth Microdilution and Disk Diffusion Results when Testing Ceftazidime-Avibactam against a Challenge Collection of Enterobacterales Isolates: Results from a Multilaboratory Study.

Authors:  Helio S Sader; Paul R Rhomberg; Sukantha Chandrasekaran; Marisol Trejo; Kelley A Fedler; Linda D Boyken; Daniel J Diekema
Journal:  J Clin Microbiol       Date:  2020-03-25       Impact factor: 5.948

5.  Assessment of 30/20-Microgram Disk Content versus MIC Results for Ceftazidime-Avibactam Tested against Enterobacteriaceae and Pseudomonas aeruginosa.

Authors:  Helio S Sader; Paul R Rhomberg; Michael D Huband; Ian A Critchley; Gregory G Stone; Robert K Flamm; Ronald N Jones
Journal:  J Clin Microbiol       Date:  2018-05-25       Impact factor: 5.948

6.  Evaluation of the Revised Ceftaroline Disk Diffusion Breakpoints When Testing a Challenge Collection of Methicillin-Resistant Staphylococcus aureus Isolates.

Authors:  Helio S Sader; Paul R Rhomberg; Timothy B Doyle; Robert K Flamm; Rodrigo E Mendes
Journal:  J Clin Microbiol       Date:  2018-11-27       Impact factor: 5.948

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.